NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch

(RTTNews) – Today’s Daily Dose brings you news about Nektar’s collaboration with Merck; Pfizer initiating a refractory multiple myeloma study; Processa Pharma’s strategic financing; and vTv Therapeutics’ initiation of a phase 1 multiple ascending dose study of HPP737. Read on…Read MoreMarketsMarkets Feed